Literature DB >> 18036449

Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates.

Earl S Ford1, Simon Capewell.   

Abstract

OBJECTIVES: The objective of our study was to examine age-specific mortality rates from coronary heart disease (CHD), particularly those among younger adults.
BACKGROUND: Trends for obesity, diabetes, blood pressure, and metabolic syndrome among young adults raise concerns about the mortality rates from CHD in this group.
METHODS: We used mortality data from 1980 to 2002 to calculate age-specific mortality rates from CHD for U.S. adults age > or =35 years.
RESULTS: Overall, the age-adjusted mortality rate decreased by 52% in men and 49% in women. Among women age 35 to 54 years, the estimated annual percentage change (EAPC) in mortality was -5.4% (95% confidence interval [CI] -5.8 to -4.9) from 1980 until 1989, -1.2% (95% CI -1.6 to -0.8) from 1989 until 2000, and 1.5% (95% CI -3.4 to 6.6) from 2000 until 2002. Among men age 35 to 54 years, the EAPC in mortality was -6.2% (95% CI -6.4 to -5.9) from 1980 until 1989, -2.3% (95% CI -2.6 to -2.1) from 1989 until 2000, and -0.5% (95% CI -3.7 to 2.9) from 2000 until 2002. Among women and men age > or =55 years, the estimated annual percentage decrease in mortality from CHD accelerated in more recent years compared with earlier periods.
CONCLUSIONS: The mortality rates for CHD among younger adults may serve as a sentinel event. Unfavorable trends in several risk factors for CHD provide a likely explanation for the observed mortality rates.

Entities:  

Mesh:

Year:  2007        PMID: 18036449     DOI: 10.1016/j.jacc.2007.05.056

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  197 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Racial/ethnic and age differences in women's awareness of heart disease.

Authors:  Heidi Mochari-Greenberger; Kerri L Miller; Lori Mosca
Journal:  J Womens Health (Larchmt)       Date:  2012-04-18       Impact factor: 2.681

3.  Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox".

Authors:  Carl J Lavie; Richard V Milani; Hector O Ventura; Abel Romero-Corral
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

4.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

5.  Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies.

Authors:  C Noel Bairey Merz; Saralyn Mark; Barbara D Boyan; Alice K Jacobs; Prediman K Shah; Leslee J Shaw; Doris Taylor; Eduardo Marbán
Journal:  J Womens Health (Larchmt)       Date:  2010-06       Impact factor: 2.681

6.  Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.

Authors:  Jo-Ann Eastwood; B Delia Johnson; Thomas Rutledge; Vera Bittner; Kerry S Whittaker; David S Krantz; Carol E Cornell; Wafia Eteiba; Eileen Handberg; Diane Vido; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2013-08-30       Impact factor: 2.681

7.  Residual cardiovascular risk in secondary prevention.

Authors:  Alberto Zambon
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

8.  Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes.

Authors:  Lori Mosca; Elizabeth Barrett-Connor; Nanette Kass Wenger
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

Review 9.  Screening low-risk individuals for coronary artery disease.

Authors:  Chintan S Desai; Roger S Blumenthal; Philip Greenland
Journal:  Curr Atheroscler Rep       Date:  2014-04       Impact factor: 5.113

Review 10.  Statin Adherence: Does Gender Matter?

Authors:  Karen M Goldstein; Leah L Zullig; Lori A Bastian; Hayden B Bosworth
Journal:  Curr Atheroscler Rep       Date:  2016-11       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.